市場調查報告書
商品編碼
1421038
全球藥物洗脫球囊市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Drug Eluting Balloon Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球藥物洗脫球囊市場需求預計將從 2023 年的 654.03 萬美元達到 2032 年近 1332.69 萬美元的市場規模,2024 - 2032 年研究期間CAGR為 8.23%。
藥物洗脫球囊(DEB)是一種用於介入性心臟病學和血管外科的醫療器材。它旨在透過結合球囊血管成形術的優點和藥物輸送功能來治療狹窄或阻塞的動脈。該裝置由塗有抗再狹窄藥物(通常是抗增殖劑)的球囊組成。
在多種因素的推動下,藥物洗脫球囊 (DEB) 市場正在經歷顯著成長。全球冠狀動脈疾病和周邊動脈疾病盛行率不斷上升是主要促進因素,從而產生了對微創治療的需求。 DEB 旨在預防球囊血管成形術後再狹窄,為解決動脈介入的常見問題提供了一種有針對性的方法。技術進步對於市場擴張至關重要,塗層技術、藥物配方和球囊設計的不斷創新提高了 DEB 的功效和安全性。 DEB 相對於其他治療方案(例如藥物洗脫支架)的偏好有助於其採用,提供藥物輸送而無需留下永久植入物的優勢。醫療保健專業人員越來越認知到藥物洗脫球囊 (DEB) 的優勢,加上良好的臨床結果,正在促進這些設備在動脈介入治療中的接受度不斷提高。監管部門的批准和有利的報銷政策也有助於提高 DEB 在臨床實踐中的可及性和採用。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球藥物洗脫球囊市場的各個細分市場進行了包容性評估。藥物洗脫球囊產業的成長和趨勢為本研究提供了整體方法。
藥物洗脫球囊市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲藥物洗脫球囊市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物洗脫球囊市場的主要參與者包括拜耳公司、美敦力、B. Braun Melsungen AG、Cook Medical, Inc.、波士頓科學公司、Becton、Dickson and Company、EuroCor、Terumo Corporation、Koninklijke Philips NV。競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Drug Eluting Balloon Market is presumed to reach the market size of nearly USD 1332.69 MN by 2032 from USD 654.03 MN in 2023 with a CAGR of 8.23% under the study period 2024 - 2032.
A drug eluting balloon (DEB) is a medical device used in interventional cardiology and vascular surgery. It is designed to treat narrowed or blocked arteries by combining the benefits of balloon angioplasty with drug-delivery capabilities. The device consists of a balloon coated with an anti-restenotic drug, typically an antiproliferative agent.
The Drug eluting balloon (DEB) market is witnessing a significant growth driven by various factors. The escalating prevalence of coronary artery disease and peripheral arterial disease globally is a primary driver, creating a demand for minimally invasive treatments. DEBs, designed to prevent restenosis after balloon angioplasty, offer a targeted approach to address a common issue in arterial interventions. Technological advancements are pivotal in market expansion, with ongoing innovations in coating technologies, drug formulations, and balloon designs enhancing the efficacy and safety of DEBs. The preference for DEBs over other treatment options, such as drug-eluting stents, contributes to their adoption, providing the advantage of drug delivery without leaving a permanent implant. The growing recognition among healthcare professionals regarding the advantages of Drug-Eluting Balloons (DEBs), coupled with favorable clinical outcomes, is fostering increased acceptance of these devices in arterial interventions. Regulatory approvals and favorable reimbursement policies also play a role enhancing the accessibility and adoption of DEBs in clinical practice.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug eluting balloon. The growth and trends of drug eluting balloon industry provide a holistic approach to this study.
This section of the drug eluting balloon market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Drug Eluting Balloon market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Eluting Balloon market include Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, Koninklijke Philips N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.